Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.870
+0.010 (0.54%)
At close: Mar 9, 2026, 4:00 PM EDT
1.840
-0.030 (-1.60%)
After-hours: Mar 9, 2026, 6:33 PM EDT
Bluejay Diagnostics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
1.82M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WORK Medical Technology Group LTD | 9.85M |
| Nuwellis | 8.17M |
| INVO Fertility | 6.94M |
| Biomerica | 4.46M |
| ENvue Medical | 2.69M |
| Catheter Precision | 730.00K |
| Tivic Health Systems | 482.00K |
| iTonic Holdings | 305.22K |
BJDX News
- 17 days ago - Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised - GlobeNewsWire
- 20 days ago - Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026 - GlobeNewsWire
- 2 months ago - Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production - GlobeNewsWire
- 5 months ago - Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewsWire
- 5 months ago - Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 5 months ago - Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform - GlobeNewsWire
- 7 months ago - Bluejay Diagnostics Provides Second Quarter Business and Corporate Update - GlobeNewsWire
- 9 months ago - Bluejay Diagnostics Provides Mid-Year Business and Corporate Update - GlobeNewsWire